Inflammatory bowel disease: Moving toward a stem cell-based therapy

Giacomo Lanzoni, Giulia Roda, Andrea Belluzi, Enrico Roda, Gian Paolo Bagnara

Research output: Contribution to journalReview articlepeer-review

61 Scopus citations

Abstract

The incidence and prevalence of Crohn's disease (CD) and ulcerative colitis (UC), the two major forms of inflammatory bowel diseases (IBD), are rising in western countries. The modern hygienic lifestyle is probably at the root of a disease where, in genetically susceptible hosts, the intestinal commensal flora triggers dysregulated immune and inflammatory responses. Current therapies ranging from antiinflammatory drugs to immunosuppressive regimens, remain inadequate. Advances in our understanding of the cell populations involved in the pathogenetic processes and recent findings on the regenerative, trophic and immunoregulatory potential of stem cells open new paths in IBD therapy. Hematopoietic and mesenchymal stem cells are catalyzing the attention of IBD investigators. This review highlights the pivotal findings for stem cell-based approaches to IBD therapy and collects the encouraging results coming in from clinical trials.

Original languageEnglish (US)
Pages (from-to)4616-4626
Number of pages11
JournalWorld Journal of Gastroenterology
Volume14
Issue number29
DOIs
StatePublished - Aug 7 2008
Externally publishedYes

Keywords

  • Inflammatory bowel disease
  • Stem cells

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Inflammatory bowel disease: Moving toward a stem cell-based therapy'. Together they form a unique fingerprint.

Cite this